Patient Right to Shop Act
If enacted, HB4712 will amend parts of the Public Health Service Act, the Employee Retirement Income Security Act, and the Internal Revenue Code, establishing clearer guidelines around the accessibility of pricing and coverage information for prescription drugs. This change aims to empower consumers, enhance competition among PBMs, and ultimately lead to more favorable drug pricing for patients. Notably, the amendments proposed in this bill would mean that health plans cannot block relevant decision-making tools that could assist consumers in navigating their prescription drug options.
House Bill 4712, also known as the Patient Right to Shop Act, is a legislative proposal aimed at enhancing oversight of pharmacy benefit management (PBM) services provided on behalf of group health plans and health insurance coverage. The bill focuses on ensuring that contracts between health insurance providers and PBM entities do not include terms that restrict access to information needed for consumer decision-support tools. Such tools are designed to inform users about the costs associated with prescription drugs, thereby facilitating more informed choices in health care expenditures.
Discussions surrounding HB4712 may center on the balance between protecting consumer rights and the operational autonomy of PBMs and health insurers. Proponents of the bill highlight the potential for increased transparency and reduced drug costs, while opponents might argue that the regulatory overhead imposed by the bill could lead to unintended consequences in the marketplace. There may also be concerns about the implications of data sharing and privacy, particularly regarding how health information will be handled under the new oversight mechanisms.